Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Times Interest Earned (2016 - 2025)

United Therapeutics' Times Interest Earned history spans 17 years, with the latest figure at $115.06 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 154.13% year-over-year to $115.06; the TTM value through Dec 2025 reached $76.54, up 138.45%, while the annual FY2025 figure was $76.54, 138.45% up from the prior year.
  • Times Interest Earned for Q4 2025 was $115.06 at United Therapeutics, down from $129.5 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $129.5 in Q3 2025 and bottomed at -$14.09 in Q1 2021.
  • The 5-year median for Times Interest Earned is $34.07 (2022), against an average of $41.61.
  • The largest annual shift saw Times Interest Earned tumbled 169.29% in 2021 before it skyrocketed 534.99% in 2022.
  • A 5-year view of Times Interest Earned shows it stood at $36.13 in 2021, then tumbled by 60.48% to $14.28 in 2022, then increased by 20.65% to $17.23 in 2023, then skyrocketed by 162.86% to $45.28 in 2024, then soared by 154.13% to $115.06 in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Times Interest Earned are $115.06 (Q4 2025), $129.5 (Q3 2025), and $49.93 (Q2 2025).